Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48-linked NADPH oxidase 4 polyubiquitination and degradation.

Abstract

BACKGROUND AND PURPOSE:

Nox4 is the major isoform of NADPH oxidase found in the kidney and contributes to the pathogenesis of diabetic nephropathy. However, the molecular mechanisms of increased Nox4 expression induced by hyperglycaemia remain to be elucidated. Here, the role of the connexin32-Nox4 signalling axis in diabetic nephropathy and its related mechanisms were investigated.

EXPERIMENTAL APPROACH:

Diabetes was induced in mice by low-dose streptozotocin (STZ) combined with a high-fat diet. Effects of connexin32 on Nox4 expression and on renal function and fibrosis in STZ-induced diabetic mice were investigated using adenovirus-overexpressing connexin32 and connexin32-deficient mice. Interactions between connexin32 and Nox4 were analysed by co-immunoprecipitation and immunofluorescence assays.

KEY RESULTS:

Connexin32 was down-regulated in the kidneys of STZ-induced diabetic mice. Overexpression of connexin32 reduced expression of Nox4 and improved renal function and fibrosis in diabetic mice, whereas connexin32 deficiency had opposite effects. Down-regulation of fibronectin expression by connexin32 was not dependent on gap junctional intercellular communication involving connexin32. Connexin32 interacted with Nox4 and reduced the generation of hydrogen peroxide, leading to the down-regulation of fibronectin expression. Mechanistically, connexin32 decreased Nox4 expression by promoting its K48-linked polyubiquitination. Interestingly, Smurf1 overexpression inhibited K48-linked polyubiquitination of Nox4. Furthermore, connexin32 interacted with Smurf1 and inhibited its expression.

CONCLUSION AND IMPLICATIONS:

Connexin32 ameliorated renal fibrosis in diabetic mice by promoting K48-linked Nox4 polyubiquitination and degradation via inhibition of Smurf1 expression. Targeting the connexin32-Nox4 signalling axis may contribute to the development of novel treatments for diabetic nephropathy.

• Authors: Zhiquan Chen, Xiaohong Sun, Qiuhong Chen, Tian Lan, Kaipeng Huang, Haiming Xiao, Zeyuan Lin, Yan Yang, Peiqing Liu, Heqing Huang
• Journal: British journal of pharmacology (Br J Pharmacol) Vol. 177 Issue 1 Pg. 145-160 (01 2020) ISSN: 1476-5381 [Electronic] England
• PMID: 31465542 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2019 The British Pharmacological Society.

Chemical References

• Connexins
• K48 capsular polysaccharide, Escherichia coli
• connexin 32
• Streptozocin
• NADPH Oxidase 4
• Nox4 protein, mouse

Topics

• Animals
• Bacterial Capsules (metabolism)
• Cells, Cultured
• Connexins (antagonists & inhibitors, metabolism)
• Diabetes Mellitus, Experimental (chemically induced, metabolism, prevention & control)
• Diabetic Nephropathies (chemically induced, metabolism, prevention & control)
• Diet, High-Fat (adverse effects)
• Fibrosis
• HEK293 Cells
• Humans
• Male
• Mice
• Mice, Inbred C57BL
• Mice, Knockout
• NADPH Oxidase 4 (antagonists & inhibitors, metabolism)
• Proteolysis (drug effects)
• Rats
• Rats, Sprague-Dawley
• Streptozocin (toxicity)
• Ubiquitination (drug effects, physiology)